Foresite Capital Management V, LLC

Foresite Capital Management V, LLC reported 9 holdings worth US$289M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Foresite Capital Management V, LLC reported 9 holdings worth US$289M as of Sep 30, 2026. Largest: CG Oncology, Inc., Latigo Biotherapeutics, Inc. and Alumis Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
9
Value as reported
US$289M

The filing in full

CompanySharesValue as reported% of portfolio
CG Oncology, Inc.1.08MUS$76.5M26.5%
Latigo Biotherapeutics, Inc.3.56MUS$59.5M20.6%
Alumis Inc.5.9MUS$43.6M15.1%
Hims & Hers Health, Inc.884KUS$26.3M9.1%
Disc Medicine, Inc.374KUS$24.5M8.5%
Odyssey Therapeutics, Inc.730KUS$16.2M5.6%
Nurix Therapeutics, Inc.459KUS$10.9M3.8%
Eikon Therapeutics, Inc.1.32MUS$10.6M3.7%
Lyell Immunopharma, Inc.0US$00.00%

Source

Download original · View original at SEC

Related